Bruce Keyt is CHIEF SCIENTIFIC OFFICER of IGM Biosciences, Inc.. Currently has a direct ownership of 242,948 shares of IGMS, which is worth approximately $3.17 Million. The most recent transaction as insider was on Jan 04, 2021, when has been sold 997 shares (Common Stock) at a price of $77.27 per share, resulting in proceeds of $77,038. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K
0.61% 3M change
75.98% 12M change
Total Value Held $3.17 Million

Bruce Keyt Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 04 2021
SELL
Payment of exercise price or tax liability
$77,038 $77.27 p/Share
997 Reduced 18.92%
4,272 Common Stock
Jan 04 2021
BUY
Exercise of conversion of derivative security
$2,325 $0.93 p/Share
2,500 Added 32.18%
5,269 Common Stock
Dec 17 2020
SELL
Open market or private sale
$139,310 $86.1 p/Share
1,618 Reduced 36.88%
2,769 Common Stock
Dec 16 2020
SELL
Payment of exercise price or tax liability
$78,833 $89.38 p/Share
882 Reduced 16.74%
4,387 Common Stock
Dec 16 2020
BUY
Exercise of conversion of derivative security
$2,325 $0.93 p/Share
2,500 Added 32.18%
5,269 Common Stock
Nov 13 2020
BUY
Grant, award, or other acquisition
$5,999 $45.45 p/Share
132 Added 4.55%
2,769 Common Stock
BK

Bruce Keyt

CHIEF SCIENTIFIC OFFICER
Mountain View, CA

Track Institutional and Insider Activities on IGMS

Follow IGM Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IGMS shares.

Notify only if

Insider Trading

Get notified when an Igm Biosciences, Inc. insider buys or sells IGMS shares.

Notify only if

News

Receive news related to IGM Biosciences, Inc.

Track Activities on IGMS